Form 4: Unity Biotechnology CFO Lynne Sullivan Sells Shares to Cover Tax Obligations
SEC Form 4
Lynne Marie Sullivan, CFO of Unity Biotechnology, sold 324 shares of common stock on June 25, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.
Summary
- Lynne Marie Sullivan, the CFO and Head of Corporate Development at Unity Biotechnology, Inc. (UBX), reported a transaction involving the sale of company stock.
- On June 25, 2024, Sullivan sold 324 shares of common stock at a price of $1.4 per share.
- The sale was executed to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units (RSUs).
- Following the transaction, Sullivan still beneficially owns 32,685 shares, which includes unvested Restricted Stock Units.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction (stock sale for tax obligations) and doesn't indicate any significant positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This particular transaction appears routine, related to tax obligations from vesting RSUs.
Key Dates
| Date | Description |
|---|---|
| 06/25/2024 | Date of stock sale transaction. |
| 06/26/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.